Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,263 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

The Norwegian Nucleoside Analogue Stop Study

NCT03681132

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Hvidovre Hospital Copenhagen, Denmark
  • St Paul Hospital Millennium Medical College Addis Ababa, Ethiopia
  • Ålesund Hospital Ålesund, Norway
  • Bodø Hospital Bodø, Norway
View Trial Details
Completed

Valproic Acid and Its Effects on HIV Latent Reservoirs

NCT00289952

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • BC St-Paul's Hospital/Immunodeficiency Clinic Vancouver, British Columbia, Canada
  • Ottawa Health Research Institute/Immunodeficiency Clinic Ottawa, Ontario, Canada
  • Actuel Medical Clinic Montreal, Quebec, Canada
  • Quartier Latin Medical Clinic Montreal, Quebec, Canada
View Trial Details
Completed

Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants

NCT03122223

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
View Trial Details
Completed

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

NCT02227238

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Rosario, Santa Fe Province, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
View all 59 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

NCT04223804

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations
  • Franco Felizarta, Md /Id# 215721 Bakersfield, California, United States
  • Ruane Clinical Research Group /ID# 224866 Los Angeles, California, United States
  • Quest Clinical Research /ID# 215796 San Francisco, California, United States
  • George Washington University Medical Faculty Associates /ID# 213893 Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details

Related conditions